EXEL
NASDAQ · Biotechnology
Exelixis Inc
$72.09
+2.52 (+3.62%)
Analyst Consensus
Hold
24
Analysts
High
Coverage
Price Target
Analyst Price Target
+61.0% upside
Low Target
$78.53
Average Target
$116.10
High Target
$123.77
Current Price
$72.09
Current
$72.09
$72.09
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Scenario Analysis
Bear Case
$78.53
8.9%
Low target
Base Case
$116.10
+61.0%
Avg target
Bull Case
$123.77
+71.7%
High target
Risk/Reward
8.0x
Highly favorable
Price in Context
52-Week High
$73.69
-2.2% from high
52-Week Low
$38.19
+88.8% from low
50-Day SMA
$60.92
+18.3% vs SMA
200-Day SMA
$51.57
+39.8% vs SMA
RSI (14)
70.6
Overbought
Target vs 52W High
$116.10
+57.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |